Observed Signal · Aug 11, 2026 · corporate_event · Source: SEC API · Impact: 2.5/5
financials Market: 8-K Financial Filing Analysis for CME Group (2026-08-11)
On August 11, 2026, CME Group Inc. filed a Form 8-K under Item 7.01 (Regulation FD Disclosure) announcing pricing changes communicated to clients via Special Executive Report No. 9799. The updated fee schedule and related notices have been made available on the company's corporate website. As a standard Item 7.01 disclosure, the filing provides notice of fee adjustments across its derivatives exchange and clearing operations without including detailed financial tables or immediate pro-forma financial updates.
Pricing adjustments directly affect CME Group's core clearing and transaction fee revenue, though the filing itself is a brief administrative Regulation FD notification directing market participants to its website.
Key Takeaways & Evidence Grounding
- CME Group announced client pricing adjustments via Special Executive Report No. 9799 on August 11, 2026.
- The disclosure was furnished under Item 7.01 (Regulation FD) and signed by Senior Managing Director, President and CFO Lynne Fitzpatrick.
- Detailed fee schedules and notice documentation were published directly on CME Group's corporate website.
Connected Companies & Entities
1 Entity mappedTrack Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.